Double-blind, Randomized, Parallel, Placebo-controlled Clinical Study to Evaluate the Viral Load of SARS-CoV-2 (COVID-19) in the Oral Cavity of SARS-CoV-2 Positive Subjects After the Use of a Mouthwash Containing Cetylpyridinium Chloride 0,07%.

NCT04757818 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

118

Enrollment

INDUSTRY

Sponsor class

Conditions

SARS-CoV-2 Infection

Interventions

OTHER: 0.07% cetylpyridinium chloride (CPC) in mouthwash
OTHER: Distilled water with the same colorant as the experimental product

Sponsor

Dentaid SL

Collaborators

[object Object]
[object Object]